ArTS Archivio della ricerca di Trieste

SAVA, GIANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.499
EU - Europa 11.708
AS - Asia 10.734
SA - Sud America 1.200
Continente sconosciuto - Info sul continente non disponibili 738
AF - Africa 262
OC - Oceania 21
Totale 50.162
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.225
SG - Singapore 4.050
CN - Cina 2.744
SE - Svezia 1.933
UA - Ucraina 1.920
PL - Polonia 1.473
IT - Italia 1.378
DE - Germania 1.293
HK - Hong Kong 1.102
BR - Brasile 951
VN - Vietnam 927
KR - Corea 726
FI - Finlandia 704
RU - Federazione Russa 693
GB - Regno Unito 643
FR - Francia 577
TR - Turchia 379
BG - Bulgaria 309
IE - Irlanda 301
BD - Bangladesh 194
IN - India 157
NL - Olanda 155
CA - Canada 132
AR - Argentina 92
MA - Marocco 81
MX - Messico 64
IQ - Iraq 60
CH - Svizzera 57
ES - Italia 54
SA - Arabia Saudita 51
ID - Indonesia 49
JP - Giappone 49
ZA - Sudafrica 40
BE - Belgio 33
EC - Ecuador 31
PK - Pakistan 31
EU - Europa 30
AT - Austria 29
CO - Colombia 28
KE - Kenya 28
SN - Senegal 28
UZ - Uzbekistan 26
VE - Venezuela 26
RO - Romania 24
EG - Egitto 23
TH - Thailandia 23
CL - Cile 22
PH - Filippine 20
PY - Paraguay 18
BA - Bosnia-Erzegovina 16
CZ - Repubblica Ceca 15
TW - Taiwan 15
MY - Malesia 14
PT - Portogallo 14
AE - Emirati Arabi Uniti 13
HN - Honduras 13
KZ - Kazakistan 13
RS - Serbia 13
TT - Trinidad e Tobago 13
AU - Australia 12
DK - Danimarca 12
JO - Giordania 12
LT - Lituania 12
TN - Tunisia 12
UY - Uruguay 12
BO - Bolivia 11
DZ - Algeria 11
JM - Giamaica 10
AZ - Azerbaigian 9
IL - Israele 9
IR - Iran 9
AL - Albania 8
BB - Barbados 8
GR - Grecia 8
NZ - Nuova Zelanda 8
CI - Costa d'Avorio 7
DO - Repubblica Dominicana 7
GE - Georgia 7
HU - Ungheria 7
NP - Nepal 7
PE - Perù 7
CR - Costa Rica 6
ET - Etiopia 6
HR - Croazia 6
NG - Nigeria 6
OM - Oman 6
GT - Guatemala 5
LB - Libano 5
QA - Qatar 5
SI - Slovenia 5
BH - Bahrain 4
GA - Gabon 4
NI - Nicaragua 4
LK - Sri Lanka 3
MD - Moldavia 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
AO - Angola 2
Totale 49.409
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.449
Singapore 2.404
Ann Arbor 2.360
Ashburn 2.008
Fairfield 1.903
Houston 1.695
Jacksonville 1.650
San Jose 1.404
Chandler 1.267
Warsaw 1.160
Wilmington 1.113
Hong Kong 1.074
Seattle 833
Hefei 799
Seoul 711
Cambridge 647
Beijing 644
Princeton 576
Council Bluffs 554
Chicago 478
Boardman 477
Columbus 421
Sofia 307
Dublin 297
Ho Chi Minh City 294
Los Angeles 289
Zgierz 281
Izmir 277
Santa Clara 267
Lauterbourg 261
Dallas 241
The Dalles 238
Moscow 230
Milan 219
Dearborn 217
Hanoi 217
Buffalo 186
Trieste 178
San Diego 139
Helsinki 114
Düsseldorf 109
New York 85
London 83
Phoenix 81
Frankfurt am Main 76
Munich 68
São Paulo 67
Casablanca 58
Falls Church 55
Verona 55
Guangzhou 53
Kocaeli 51
Norwalk 48
Amsterdam 46
Redwood City 46
Shanghai 46
Kunming 45
Orem 44
Bern 43
Da Nang 42
Nanjing 42
Bremen 41
Mestre 40
Rio de Janeiro 40
Tokyo 39
Salt Lake City 38
Turku 38
Des Moines 35
Tianjin 34
Jinan 33
Miano 33
Haiphong 32
Montreal 32
San Francisco 31
Atlanta 30
Denver 30
Brooklyn 29
Brussels 29
Rome 29
Chennai 28
Dakar 28
Nairobi 25
Hangzhou 24
North Bergen 24
Toronto 24
Tashkent 23
Poplar 22
Porto Alegre 22
Mexico City 21
Zhengzhou 21
Andover 20
Johannesburg 20
Redondo Beach 20
Tampa 20
Belo Horizonte 19
Elk Grove Village 19
Jeddah 19
Vienna 19
Baghdad 18
Brasília 18
Totale 33.189
Salva come PNG Salva come JPEG
Nome #
The differential distribution of RAPTA-T in non-invasive and invasive breast cancer cells correlates with its anti-invasive and anti-metastatic effects 651
Effects of Two Fullerene Derivatives on Monocytes and Macrophages 476
Colorectal Cancer Metastases Settle in the Hepatic Microenvironment Through α5β1 Integrin 415
Identification and Characterization of a Novel Family of Cysteine-Rich Peptides (MgCRP-I) from Mytilus galloprovincialis 383
Pharmacological activities of ruthenium complexes related to their NO scavenging properties 374
Chemical and Molecular Approach to Tumor Metastases 353
A Cationic [60] Fullerene Derivative Reduces Invasion and Migration of HT-29 CRC Cells in Vitro at Dose Free of Significant Effects on Cell Survival 327
Analysis of the cytotoxicity of synthetic antimicrobial peptides on mouse leucocytes: implications for systemic use. 319
Influence of components of tumour microenvironment on the response of HCT-116 colorectal cancer to the ruthenium-based drug NAMI-A 297
New salts of anionic complexes of Ru(III) as antimetastatic and antineoplastic agents. 281
Complessi dicarbossilati del rutenio(II) e loro impiego come antitumorali 262
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy 259
Can peptides be orally-delivered in crustaceans? The case study of the Crustacean Hyperglycaemic Hormone in Procambarus clarkii 257
Sulfoxide ruthenium complexes: non toxic tools for the selective treatment of solid tumour metastases. 253
A novel retinoic/butyric hyaluronan ester for the treatment of acute promyelocytic leukemia: preliminary preclinical results 251
Antitumor action of mer-trichlorobis(dimethyl sulfoxide)aminoruthenium(III) (BBR2382) in mice bearing Lewis lung carcinoma 249
Antimetastatic Action and Lymphocyte Activation by the Modified Lysozyme Lyso-M-PEG in Mice with Mca Mammary Carcinoma 248
Chemical, biological and antitumor properties of ruthenium(II) complexes with dimethylsulfoxide 244
Influence of the anionic ligands on the anticancer activity of Ru(II)-dmso complexes: Kinetics of aquation and in vitro cytotoxicity of new dicarboxylate compounds in comparison with their chloride precursors 244
Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK 243
Response of MCa mammary carcinoma to cisplatin and to Na[trans-RuCl4(DMSO)(Im)]. 241
Antitumor properties of ruthenium(II)-dimethylsulfoxide complexes in the Lewis lung carcinoma system 238
Antineoplastic activity and toxicity of an organometallic complex of ruthenium(II) in comparison with cis-PDD in mice bearing solid malignant neoplasms 238
Antitumor effects of rhodium(I), iridium(I) and ruthenium(II) complexes in comparison with cis-dichloro-diamminoplatinum(II) in mice bearing Lewis lung carcinoma 237
Effects of lysozyme on spleen and lungs in mice with Lewis lung carcinoma 235
Ruthenium(III) complexes as antineoplastic agents. 234
Antimetastatic action and lymphocyte activation by the modified lysozyme mPEG-Lyso in mice with MCa mammary carcinoma 234
Antitumour properties of dimethylsulphoxide ruthenium (II) complexes in theLewis lung carcinoma system. 233
trans-Ru(II)dimethylsulfoxides: antineoplastic action on mouse tumors 231
The antimetastatic drug NAMI-A potentiates the phenylephrine-induced contraction of aortic smooth muscle cells and induces a transient increase in systolic blood pressure 231
Dual action of NAMI-A in inhibition of solid tumor metastasis: Selective targeting of metastatic cells and binding to collagen 230
Tumor inhibition and effects on host survival time by rutheniumIII andrhodiumIII complexes with dimethylsulphoxide ligands. 228
Antineoplastic effects of mer-RuCl3(DMSO)2(NH3) against murine tumors: comparison with cisplatin and with ImH[RuIm2Cl4]. 228
Reconsidering clinical pharmacology frameworks as a necessary strategy for improving the health care of patients: a systematic review 228
Ruthenium-Porphyrin Conjugates with Cytotoxic and Phototoxic Antitumor Activity 227
RNA-seq analysis of the whole transcriptome of MDA-MB-231 mammary carcinoma cells exposed to the antimetastatic drug NAMI-A 227
Antiinflammatory action of hydrosoluble dimethyltriazenes on the carrageenin-induced edema in guinea pigs 222
Antimetastatic action and toxicity on healty tissues of Na[trans-RuCl4(DMSO)Im] in the mouse. 221
Antitumor and antimetastatic effects of benzenoid triazenes in mice bearing Lewis lung carcinoma. 221
Antimetastatic action of the prostacyclin analog Iloprost in the mouse 221
Reduction of lung metastases by Na[trans-RuCl4(DMSO)Im] is not coupled with the induction of chemical xenogenization 220
Antimetastatic action and toxicity on healthy tissues ofNa[trans-RuCl4(DMSO)Im] in the mouse. 219
Antileukemic action of RuCl2(DMSO)4 isomers and prevention of brain involvement on P388 leukemia and on P388/DDP subline 219
Actin-dependent tumour cell adhesion after short-term exposure to the antimetastasis ruthenium complex NAMI-A 216
Complessi di Rutenio con elevata attività antitumorale 216
Rhodium(III) analogues of antitumour-active ruthenium(III) compounds: the crystal structure of [ImH][trans-RhCl4(Im)2] (Im= imidazole) 215
Age Dependent Modification of the Metabolic Profile of the Tibialis Anterior Muscle Fibers in C57BL/6J Mice 215
Orally administered microencapsulated lysozyme downregulates serum AGE and reduces the severity of early-stage diabetic nephropathy 214
Effects of antimetastatic, antiinvasive and cytotoxic agents on the growth and spread of transplantable leukemias in mice. 213
Efficacy of 5-FU combined to Na[trans-RuCl4(DMSO)(Im)], a novel selective antimetastatic agent, on the survival time of mice with P388 leukemia, P388/DDP subline and MCa mammary carcinoma 212
Complessi trans di rutenio come agenti antineoplastici 211
Biochemical and biological characteristics of leucocyte proteinase inhibitors. 211
Antimetastatic effects of N-diazoacetyl-glycine derivatives in C57BL mice. 210
Free exchange across cells,and echistatin-sensitive membrane target for the metastasis inhibitor NAMI-A(imidazolium trans-imidazole dimethyl sulfoxide tetrachlororuthenate)ON KB Tumor cells. 209
Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds Na2[{trans-RuCl4(Me2SO)}2(μ-L)] (L=ditopic, non-chelating aromatic N-ligand). A preliminary investigation 209
Features and full reversibility of the renal toxicity of the ruthenium-based drug NAMI-A in mice 209
Hydrophilic polymer coated monodispersed Fe3O4 nanostructures and their cytotoxicity 206
The mechanism of tumour cell death by metal-based anticancer drugs is not only a matter of DNA interactions 206
The development of tumor-inhibiting ruthenium dimethylsulfoxide complexes 205
Inhibition of adhesion, migration and of α5β1 integrin in the HCT-116 colorectal cancer cells treated with the ruthenium drug NAMI-A 205
Antimetastatic effects and tumor proteinase inhibition by spleen intracellular inhibitors of neutral proteinases. 204
Effects of an inducer and an inhibitor of hepatic metabolism on the antitumor action of dimethyltriazenes 204
Study of a potential drug delivery system based on carbon nanoparticles: Effects of fullerene derivatives in MCF7 mammary carcinoma cells 204
Effects of endotoxin in mice bearing solid metastasizing tumors and treated with lysozyme hydrochloride 204
A review on usnic acid, an interesting natural compound 203
Ruthenium complexes can target determinants of tumour malignancy 203
In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes 203
Tuning the hydrophobicity of ruthenium(ii)-arene (RAPTA) drugs to modify uptake, biomolecular interactions and efficacy 203
Effects of L-(adamant-2-yl)glycyl-L-alanyl-D-isoglutamine on the antitumor action of cyclophosphamide, 5-FU, cisplatin and dacarbazine on advanced carcinomas of the mouse 203
Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A 202
Antitumor effects of GANU and other nitrosourea derivatives against transplantable leukemias and solid tumors in mice. 202
Approaching tumour therapy beyond platinum drugs. Status of the art and perspectives of ruthenium drug candidates. 202
Antineoplastic action of egg-white lysozyme on the growth of MCa mammary carcinoma and TLX5 lymphoma in the CBA mouse. 201
Methodologic problems encountered in the assay of proteinases in Lewis lung carcinoma, a mouse metastasizing tumor. 201
Antitumor action of rhodium(I) and iridium(I) complexes 201
Human recombinant lysozyme downregulates advanced glycan endproduct-induced interleukin-6 production and release in an in vitro model of human proximal tubular epithelial cells 201
Half-sandwich RuIIsingle bond[9]aneS3 complexes structurally similar to antitumor-active organometallic piano-stool compounds: Preparation, structural characterization and in vitro cytotoxic activity 201
Na[trans-RuCl4(DMSO)(Im)]*2DMSO - antimetastatic ruthenium agent 200
Long-term resveratrol treatment improves the capillarization in the skeletal muscles of ageing C57BL/6J mice 200
Antiviral properties and cytotoxic activity of platinum(II) complexes with 1,10-phenanthrolines and acyclovir or penciclovir 199
Anticancer ruthenium complexes 199
Microcapsule a doppio strato di polisaccaridiutilizzabili come veicoli per la somministrazione oraledi sostanze biologicamente attive 198
Antineoplastic action of p-(3-methyl-1-triazeno) benzoic acid potassium salt, monomethylderivative of the antimetastatic compound DM-COOK 198
Metal-based antitumour drugs in the post-genomic era: what comes next? 198
Effects of trans-RuCl2 (DMSO)4 on B16 melanoma in mice. 196
Inhibition of B16 Melanoma Metastases with the Ruthenium Complex Imidazolium trans-Imidazoledimethylsulfoxide-tetrachlororuthenate and Down-Regulation of Tumor Cell Invasion. 196
Chemical, biological and antitumor properties of ruthenium-dimethylsulfoxide complexes 196
Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs 196
A kinetic study of the chemical stability of the antimetastatic ruthenium complex NAMI-A. 194
Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data 194
Distinct effects of dinuclear ruthenium(III) complexes on cell proliferation and on cell cycle regulation in human and murine tumor cell lines. 193
Ruthenium antimetastatic agents 192
Metal-Based Inhibition of Poly(ADP-ribose) Polymerase - The Guardian Angel of DNA 192
Down-regulation of tumour gelatinase/inhibitor balance and preservation of tumour endothelium by an antimetastatic ruthenium complex 191
Stimulation of GALT and Activation of Mesenteric Lymphonode Lymphocytes by a Modifìed Iysozyme in CBA Mice with Mca mammary carcinoma 190
Synthesis and characterization of a diruthenium(II,III)-ketoprofen compound and study of the in vitro effects on CRC cells in comparison to the naproxen and ibuprofen derivatives 190
Profiling the molecular mechanism of fullerene cytotoxicity on tumor cells by RNA-seq 190
Influence of the binding of reduced NAMI-A to human serum albumin on the pharmacokinetics and biological activity 190
Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers 189
Antitumor activity of N-diazoacetyl derivatives of glycine and phenylalanine against P388 leukemia and B16 melanoma in mice. 189
Totale 23.143
Salva come PNG Salva come JPEG
Categoria #
all - tutte 149.292
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 149.292
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.874 0 0 187 463 49 257 137 116 386 345 200 734
2022/20233.888 426 429 284 486 445 737 9 354 474 23 158 63
2023/20241.932 163 134 109 112 221 92 245 504 29 35 141 147
2024/20255.277 96 157 510 422 495 511 430 310 720 559 441 626
2025/202613.017 1.275 830 1.086 1.082 1.082 1.316 2.023 454 1.381 1.668 435 385
2026/20271.643 387 759 497 0 0 0 0 0 0 0 0 0
Totale 50.162